These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 17565496)

  • 41. Positioning of 99mTc-chelators influences radiolabeling, stability and biodistribution of Affibody molecules.
    Ekblad T; Orlova A; Feldwisch J; Wennborg A; Karlström AE; Tolmachev V
    Bioorg Med Chem Lett; 2009 Jul; 19(14):3912-4. PubMed ID: 19364646
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HEHEHE-tagged affibody molecule may be purified by IMAC, is conveniently labeled with [⁹⁹(m)Tc(CO)₃](+), and shows improved biodistribution with reduced hepatic radioactivity accumulation.
    Tolmachev V; Hofström C; Malmberg J; Ahlgren S; Hosseinimehr SJ; Sandström M; Abrahmsén L; Orlova A; Gräslund T
    Bioconjug Chem; 2010 Nov; 21(11):2013-22. PubMed ID: 20964447
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [99mTc]Demotensin 5 and 6 in the NTS1-R-targeted imaging of tumours: synthesis and preclinical results.
    Maina T; Nikolopoulou A; Stathopoulou E; Galanis AS; Cordopatis P; Nock BA
    Eur J Nucl Med Mol Imaging; 2007 Nov; 34(11):1804-14. PubMed ID: 17594090
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vivo and in vitro studies on renal uptake of radiolabeled affibody molecules for imaging of HER2 expression in tumors.
    Altai M; Varasteh Z; Andersson K; Eek A; Boerman O; Orlova A
    Cancer Biother Radiopharm; 2013 Apr; 28(3):187-95. PubMed ID: 23461385
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Increasing the Net Negative Charge by Replacement of DOTA Chelator with DOTAGA Improves the Biodistribution of Radiolabeled Second-Generation Synthetic Affibody Molecules.
    Westerlund K; Honarvar H; Norrström E; Strand J; Mitran B; Orlova A; Eriksson Karlström A; Tolmachev V
    Mol Pharm; 2016 May; 13(5):1668-78. PubMed ID: 27010700
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Design, Preparation, and Characterization of PNA-Based Hybridization Probes for Affibody-Molecule-Mediated Pretargeting.
    Westerlund K; Honarvar H; Tolmachev V; Eriksson Karlström A
    Bioconjug Chem; 2015 Aug; 26(8):1724-36. PubMed ID: 26086597
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Radiolabeled affibody-albumin bioconjugates for HER2-positive cancer targeting.
    Hoppmann S; Miao Z; Liu S; Liu H; Ren G; Bao A; Cheng Z
    Bioconjug Chem; 2011 Mar; 22(3):413-21. PubMed ID: 21299201
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of benzoate- and dodecaborate-based linkers for attachment of radioiodine to HER2-targeting Affibody ligand.
    Tran T; Orlova A; Sivaev I; Sandström M; Tolmachev V
    Int J Mol Med; 2007 Mar; 19(3):485-93. PubMed ID: 17273798
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of affinity matured Affibody molecules for imaging of the immune checkpoint protein B7-H3.
    Oroujeni M; Bezverkhniaia EA; Xu T; Liu Y; Plotnikov EV; Klint S; Ryer E; Karlberg I; Orlova A; Frejd FY; Tolmachev V
    Nucl Med Biol; 2023; 124-125():108384. PubMed ID: 37699299
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Targeting of HER2-expressing tumors using 111In-ABY-025, a second-generation affibody molecule with a fundamentally reengineered scaffold.
    Ahlgren S; Orlova A; Wållberg H; Hansson M; Sandström M; Lewsley R; Wennborg A; Abrahmsén L; Tolmachev V; Feldwisch J
    J Nucl Med; 2010 Jul; 51(7):1131-8. PubMed ID: 20554729
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Incorporation of a triglutamyl spacer improves the biodistribution of synthetic affibody molecules radiofluorinated at the N-terminus via oxime formation with (18)F-4-fluorobenzaldehyde.
    Rosik D; Thibblin A; Antoni G; Honarvar H; Strand J; Selvaraju RK; Altai M; Orlova A; Eriksson Karlström A; Tolmachev V
    Bioconjug Chem; 2014 Jan; 25(1):82-92. PubMed ID: 24344772
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Selection of an optimal cysteine-containing peptide-based chelator for labeling of affibody molecules with (188)Re.
    Altai M; Honarvar H; Wållberg H; Strand J; Varasteh Z; Rosestedt M; Orlova A; Dunås F; Sandström M; Löfblom J; Tolmachev V; Ståhl S
    Eur J Med Chem; 2014 Nov; 87():519-28. PubMed ID: 25282673
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of a maleimido derivative of CHX-A'' DTPA for site-specific labeling of affibody molecules.
    Tolmachev V; Xu H; Wållberg H; Ahlgren S; Hjertman M; Sjöberg A; Sandström M; Abrahmsén L; Brechbiel MW; Orlova A
    Bioconjug Chem; 2008 Aug; 19(8):1579-87. PubMed ID: 18620447
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An improved radiolabelled RNA aptamer molecule for HER2 imaging in cancers.
    Varmira K; Hosseinimehr SJ; Noaparast Z; Abedi SM
    J Drug Target; 2014 Feb; 22(2):116-22. PubMed ID: 24098950
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Influence of valency and labelling chemistry on in vivo targeting using radioiodinated HER2-binding Affibody molecules.
    Tolmachev V; Mume E; Sjöberg S; Frejd FY; Orlova A
    Eur J Nucl Med Mol Imaging; 2009 Apr; 36(4):692-701. PubMed ID: 19066886
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HER2-positive tumors imaged within 1 hour using a site-specifically 11C-labeled Sel-tagged affibody molecule.
    Wållberg H; Grafström J; Cheng Q; Lu L; Martinsson Ahlzén HS; Samén E; Thorell JO; Johansson K; Dunås F; Olofsson MH; Stone-Elander S; Arnér ES; Ståhl S
    J Nucl Med; 2012 Sep; 53(9):1446-53. PubMed ID: 22872744
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Direct comparison of 111In-labelled two-helix and three-helix Affibody molecules for in vivo molecular imaging.
    Rosik D; Orlova A; Malmberg J; Altai M; Varasteh Z; Sandström M; Karlström AE; Tolmachev V
    Eur J Nucl Med Mol Imaging; 2012 Apr; 39(4):693-702. PubMed ID: 22170322
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Influence of macrocyclic chelators on the targeting properties of (68)Ga-labeled synthetic affibody molecules: comparison with (111)In-labeled counterparts.
    Strand J; Honarvar H; Perols A; Orlova A; Selvaraju RK; Karlström AE; Tolmachev V
    PLoS One; 2013; 8(8):e70028. PubMed ID: 23936372
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of in vitro and in vivo properties of [99mTc]cRGD peptides labeled using different novel Tc-cores.
    Decristoforo C; Santos I; Pietzsch HJ; Kuenstler JU; Duatti A; Smith CJ; Rey A; Alberto R; Von Guggenberg E; Haubner R
    Q J Nucl Med Mol Imaging; 2007 Mar; 51(1):33-41. PubMed ID: 17372571
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.